Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in PediatricsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Quality of life for children with chronic kidney disease.Semin Nephrol. 2006; 18: 114-117
- Health-related quality of life of children with mild to moderate chronic kidney disease.Pediatrics. 2010; 125: e349-e357
- Children's experiences of dialysis: a systematic review of qualitative studies.Arch Dis Child. 2012; 97: 395
- Overview of chronic kidney disease in children.Curr Opin Pediatr. 2010; 22: 158-160
- CKiD (CKD in children) prospective cohort study: a review of current findings.Am J Kidney Dis. 2012; 60: 1002-1011
- Epidemiology of chronic kidney disease in children.Pediatr Nephrol. 2012; 27: 363-373
- Chronic kidney disease in children: the global perspective.Pediatr Nephrol. 2007; 22: 1999-2009
- Impact of obesity on kidney function and blood pressure in children.World J Nephrol. 2015; 4: 223-229
- Risk factors for progression of chronic kidney disease.Curr Opin Pediatr. 2010; 22: 161-169
- Albuminuria, Proteinuria, and renal disease progression in children with CKD.Clin J Am Soc Nephrol. 2017; 12: 912-920
- Therapeutic strategies to slow chronic kidney disease progression.Pediatr Nephrol. 2008; 23: 705
- Low birth weight increases risk for end-stage renal disease.J Am Soc Nephrol. 2008; 19: 151-157
- Short-term gestation, long-term risk: prematurity and chronic kidney disease.Pediatrics. 2013; 131: 1168-1179
- Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children.Clin J Am Soc Nephrol. 2011; 6: 856-863
- Evidence-based guidelines for the management of hypertension in children with chronic kidney disease.Pediatr Nephrol. 2015; 30: 1919-1927
- Losartan and enalapril are comparable in reducing proteinuria in children.Kidney Int. 2012; 82: 819-826
- Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD.Pediatr Nephrol. 2017; 32: 643-649
- Validation of a simple equation for glomerular filtration rate measurement based on plasma iohexol disappearance.Clin Kidney J. 2019; 13: 397-401
- Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C.Kidney Int. 2012; 82: 445-453
- Cystatin C as a biomarker for estimating glomerular filtration rate.Curr Opin Nephrol Hypertens. 2015; 24: 295-300
- New equations to estimate GFR in children with CKD.J Am Soc Nephrol. 2009; 20: 629-637
- Measurement and estimation of GFR in children and adolescents.J Am Soc Nephrol. 2009; 4: 643-1832
- Prevalence of complications in children with chronic kidney disease according to KDOQI.Kidney Int. 2006; 70: 585-590
- Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.Kidney Int S. 2013; 3: 1-150
- National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.Pediatrics. 2003; 111: 1416-1421
- Chronic kidney disease in children.Clin Kidney J. 2016; 9: 583-591
- Estimating time to ESRD in children with CKD.Am J Kidney Dis. 2018; 71: 783-792
- Metabolic acidosis in CKD: A review of recent findings.Kidney Med. 2021; 3: 267-277
- Metabolic acidosis and the progression of chronic kidney disease.BMC Nephrol. 2014; 15
- Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.Kidney Int. 2017; 92: 1507-1514
- Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.Pediatr Nephrol. 2021; 36: 83-91
- Bone disease in pediatric chronic kidney disease.Pediatr Nephrol. 2013; 28: 569-576
- Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease.Am J Kidney Dis. 2005; 46: S12
- Metabolic bone disease in chronic kidney disease.J Am Soc Nephrol. 2007; 18: 875-885
- The “phosphorus pyramid”: a visual tool for dietary phosphate management in dialysis and CKD patients.BMC Nephrol. 2015; 16
- The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the pediatric renal nutrition taskforce.Pediatr Nephrol. 2020; 35: 501-518
- Interventions for metabolic bone disease in children with chronic kidney disease.Cochrane Database Syst Rev. 2015; 11
- Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.Pediatr Nephrol. 2006; 21: 151-159
- Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product.Am J Nephrol. 2003; 23: 369-379
- Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis.Pediatr Nephrol. 2020; 35: 1679-1697
- Anemia in children with chronic kidney disease.Adv Chronic Kidney Dis. 2005; 12: 385-396
- Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist.Pediatr Nephrol. 2012; 27: 33-40
- Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study.Pediatr Nephrol. 2016; 31: 443-453
- Clinical practice recommendations for anemia in chronic kidney disease in children.Am J Kidney Dis. 2006; 47: S86-S108
- Anemia and health-related quality of life in adolescents with chronic kidney disease.Am J Kidney Dis. 2004; 44: 1017-1023
- Cardiovascular complications of pediatric chronic kidney disease.Pediatr Nephrol. 2008; 23: 27-39
- A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure.Nephrol Dial Transpl. 2010; 25: 785-793
- Cardiovascular disease risk in children with kidney disease.Semin Nephrol. 2018; 38: 298-313
- Carotid intima-media thickness in children with CKD: results from the CKiD study.Clin J Am Soc Nephrol. 2012; 7: 1930-1937
- Adiposity, sex, and cardiovascular disease risk in children with CKD: a longitudinal study of youth enrolled in the Chronic Kidney Disease in Children (CKiD) study.Am J Kidney Dis. 2020; 76: 166-173
- Pretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice.Clin Kidney J. 2018; 11: 166-171
- Nutritional challenges across the spectrum of chronic kidney disease.Asian J Pediatr Nephrol. 2019; 2: 2-15
- Gastrostomy feeding in infants and children on peritoneal dialysis.Pediatr Nephrol. 2002; 17: 246-250
- The impact of short stature on health-related quality of life in children with chronic kidney disease.J Pediatr. 2013; 163: 736-741
- Growth hormone and insulin-like growth factor dysregulation in pediatric chronic kidney disease.Horm Res Paediatr. 2021; 94: 105-114
- Treatment of growth retardation in a child with CKD.Clin J Am Soc Nephrol. 2019; 14: 1658-1660
- Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.Pediatr Nephrol. 2006; 21: 917-930
- Growth hormone axis in chronic kidney disease.Pediatr Nephrol. 2008; 23: 41-48
- Clinical practice guidelines for nutrition in chronic renal failure.Am J Kidney Dis. 2000; 35: S1
- Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease.Nat Rev Nephrol. 2019; 15: 577-589
- Renal replacement therapy in children: data from 12 registries in Europe.Pediatr Nephrol. 2004; 19: 213-221
- Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe: an ESPN-ERA/EDTA registry analysis.Lancet. 2017; 389: 2128
- Vaccine administration in children with chronic kidney disease.Vaccine. 2014; 32: 6601-6606
- Immunizations in children with chronic kidney disease.Pediatr Nephrol. 2012; 27: 1257-1263
- Social consequences in adult life of end-stage renal disease in childhood.J Pediatr. 2005; 146: 512
- Impact of renal replacement therapy in childhood on long-term socioprofessional outcomes: a 30-year follow-up study.J Pediatr. 2016; 171: 189
Article Info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
